1,233
Views
136
CrossRef citations to date
0
Altmetric
Reviews

Targeting the ubiquitin–proteasome system for cancer therapy

, , & , PhD
Pages 1091-1108 | Published online: 04 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Jinhua Zhang, Jing Si, Lu Gan, Cuixia Di, Yi Xie, Chao Sun, Hongyan Li, Menghuan Guo & Hong Zhang. (2019) Research progress on therapeutic targeting of quiescent cancer cells. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 2810-2819.
Read now
Willy Roque, Ross Summer & Freddy Romero. (2019) Fine-tuning the ubiquitin-proteasome system to treat pulmonary fibrosis. Connective Tissue Research 60:1, pages 50-61.
Read now
Richard Arkwright, Tri Minh Pham, Jeffrey A. Zonder & Q. Ping Dou. (2017) The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma. Expert Opinion on Drug Discovery 12:2, pages 225-235.
Read now
Xu Li, Feng Zhu, Jianxin Jiang, Chengyi Sun, Qing Zhong, Ming Shen, Xin Wang, Rui Tian, Chengjian Shi, Meng Xu, Feng Peng, Xingjun Guo, Jun Hu, Dawei Ye, Min Wang & Renyi Qin. (2016) Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells. Autophagy 12:9, pages 1521-1537.
Read now
Massimo Offidani, Laura Corvatta, Silvia Gentili, Laura Maracci & Pietro Leoni. (2016) Oral ixazomib maintenance therapy in multiple myeloma. Expert Review of Anticancer Therapy 16:1, pages 21-32.
Read now
Pershang Farshi, Rahul R Deshmukh, Joseph O Nwankwo, Richard T Arkwright, Boris Cvek, Jinbao Liu & Q Ping Dou. (2015) Deubiquitinases (DUBs) and DUB inhibitors: a patent review. Expert Opinion on Therapeutic Patents 25:10, pages 1191-1208.
Read now
Jason B Kaplan, Joan Guitart & Francis J Giles. (2014) Targeted therapies for cutaneous T-cell lymphomas. Expert Review of Hematology 7:4, pages 481-493.
Read now

Articles from other publishers (129)

Priyanka S. Rana, James J. Ignatz-Hoover & James J. Driscoll. (2023) Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases. Cancers 15:23, pages 5632.
Crossref
Xiaoting Yang, Jing Wang & Wei Liu. (2023) Molecular markers of type II alveolar epithelial cells in acute lung injury by bioinformatics analysis. Scientific Reports 13:1.
Crossref
Rong Liang, Huabing Tan, Honglin Jin, Jincheng Wang, Zijian Tang & Xiaojie Lu. (2023) The tumour-promoting role of protein homeostasis: Implications for cancer immunotherapy. Cancer Letters 573, pages 216354.
Crossref
Zijun Guo & Lin Guo. (2023) Tumor-promoting action of ubiquitin protease 43 in gastric cancer progression through deubiquitination and stabilization of stress-inducible phosphoprotein 1. Experimental Cell Research 430:2, pages 113714.
Crossref
Xiaoyan Tang, Ruiqiang Weng, Guixian Guo, Juexian Wei, Xueqiang Wu, Bin Chen, Sudong Liu, Zhixiong Zhong & Xiaohui Chen. (2023) USP10 regulates macrophage inflammation responses via stabilizing NEMO in LPS-induced sepsis. Inflammation Research.
Crossref
Kyota Ishii, Mayuko Hido, Misaki Sakamura, Nantiga Virgona & Tomohiro Yano. (2023) α-Tocotrienol and Redox-Silent Analogs of Vitamin E Enhances Bortezomib Sensitivity in Solid Cancer Cells through Modulation of NFE2L1. International Journal of Molecular Sciences 24:11, pages 9382.
Crossref
Chao Chen, Ying Wang, Qing Zhao, Guo-dong Li, Yao-hui Wang, Li-chao Xu, Hao-zhe Huang, Ge Song, Wen-tao Li & Xin-hong He. (2023) E3 Ubiquitin Ligase MARCH8 Promotes Pancreatic Cancer Growth and Metastasis by Activating STAT3 via Degradation of PTPN4. Pancreas 52:4, pages e224-e234.
Crossref
Christophe Le Priol, Chloé-Agathe Azencott & Xavier Gidrol. (2023) Detection of genes with differential expression dispersion unravels the role of autophagy in cancer progression. PLOS Computational Biology 19:3, pages e1010342.
Crossref
Albano Toska, Nikita Modi & Lin-Feng Chen. (2023) RUNX3 Meets the Ubiquitin-Proteasome System in Cancer. Cells 12:5, pages 717.
Crossref
Yanan Cui, Lijuan Luo, Zihang Zeng, Xiangming Liu, Tiao Li, Xue He, Yiming Ma, Weiwei Meng, Huihui Zeng, Yingjiao Long, Dandan Zong & Yan Chen. (2023) MFG-E8 stabilized by deubiquitinase USP14 suppresses cigarette smoke-induced ferroptosis in bronchial epithelial cells. Cell Death & Disease 14:1.
Crossref
Narathip Naradun, Krajang Talabnin, Kanyavee Issarangkul na Ayuttha & Chutima Talabnin. (2022) Piperlongumine and bortezomib synergically inhibit cholangiocarcinoma via ER stress–induced cell death. Naunyn-Schmiedeberg's Archives of Pharmacology 396:1, pages 109-120.
Crossref
Betul Celik, Kader Cicek, Andrés Felipe Leal & Shunji Tomatsu. (2022) Regulation of Molecular Targets in Osteosarcoma Treatment. International Journal of Molecular Sciences 23:20, pages 12583.
Crossref
Wangyang Zheng, Yuling Zheng, Xue Bai, Yongxu Zhou, Liang Yu, Daolin Ji, Kaiming Leng, Nanfeng Meng, Hang Wang, ZiYue Huang, Yi Xu & Yunfu Cui. (2022) RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma. Journal of Oncology 2022, pages 1-17.
Crossref
Berkcan Dogan, Ece Gumusoglu, Ege Ulgen, Osman Ugur Sezerman & Tuba Gunel. (2022) Integrated bioinformatics analysis of validated and circulating miRNAs in ovarian cancer. Genomics & Informatics 20:2, pages e20.
Crossref
Alexandra Daks, Olga Fedorova, Sergey Parfenyev, Ivan Nevzorov, Oleg Shuvalov & Nickolai A. Barlev. (2022) The Role of E3 Ligase Pirh2 in Disease. Cells 11:9, pages 1515.
Crossref
Yujie Deng, Xiaohui Chen, Chuanzhong Huang, Jun Song, Sisi Feng, Xuzheng Chen & Ruixiang Zhou. (2022) Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma. Journal of Oncology 2022, pages 1-17.
Crossref
Rongfu Tu, Junpeng Ma, Peng Zhang, Ye Kang, Xiaofan Xiong, Junsheng Zhu, Miao Li & Chengsheng Zhang. (2022) The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism. Cancer Cell International 22:1.
Crossref
Grazia Raffaella Tundo, Diego Sbardella, Francesco Oddone, Giuseppe Grasso, Stefano Marini, Maria Grazia Atzori, Anna Maria Santoro, Danilo Milardi, Francesco Bellia, Gabriele Macari, Grazia Graziani, Fabio Polticelli, Paolo Cascio, Mariacristina Parravano & Massimo Coletta. (2022) Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug. Biomolecules 12:2, pages 315.
Crossref
Felipe C. Demidoff, Magdalena N. Rennó & Chaquip D. Netto. 2022. 45 70 .
Anmol Sharma, Heena Khan, Thakur Singh, Amarjot Grewal, Agnieszka Najda, Małgorzata Kawecka-Radomska, Mohamed Kamel, Ahmed Altyar & Mohamed Abdel-Daim. (2021) Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling. International Journal of Molecular Sciences 22:21, pages 11971.
Crossref
Natalia Lopez-Gonzalez del Rey, Tiziano Balzano, Lucia Martin-Rodriguez, Constanza Salinas-Rebolledo, Ines Trigo-Damas, Alejandro Rojas-Fernandez, Lydia Alvarez-Erviti & Javier Blesa. (2021) Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala. Frontiers in Aging Neuroscience 13.
Crossref
Lisa Traeger, Steffen B. Wiegand, Andrew J. Sauer, Benjamin H.P. Corman, Kathryn M. Peneyra, Florian Wunderer, Anna Fischbach, Aranya Bagchi, Rajeev Malhotra, Warren M. Zapol & Donald B. Bloch. (2021) UBA6 and NDFIP1 regulate the degradation of ferroportin. Haematologica 107:2, pages 478-488.
Crossref
Hanieh Nargeh, Fatemeh Aliabadi, Marjan Ajami & Hamidreza Pazoki-Toroudi. (2021) Role of Polyphenols on Gut Microbiota and the Ubiquitin-Proteasome System in Neurodegenerative Diseases. Journal of Agricultural and Food Chemistry 69:22, pages 6119-6144.
Crossref
Imane Bjij, Ismail Hdoufane, Mahmoud Soliman, Menče Najdoska-Bogdanov & Driss Cherqaoui. (2021) Targeting Protein Degradation in Cancer Treatment. Current Chemical Biology 15:1, pages 5-18.
Crossref
Tiao Li, Xue He, Lijuan Luo, Huihui Zeng, Siying Ren & Yan Chen. (2021) F-Box Protein FBXW17-Mediated Proteasomal Degradation of Protein Methyltransferase PRMT6 Exaggerates CSE-Induced Lung Epithelial Inflammation and Apoptosis. Frontiers in Cell and Developmental Biology 9.
Crossref
Man Chun John Ma, Saber Tadros, Alyssa Bouska, Tayla Heavican, Haopeng Yang, Qing Deng, Dalia Moore, Ariz Akhter, Keenan Hartert, Neeraj Jain, Jordan Showell, Sreejoyee Ghosh, Lesley Street, Marta Davidson, Christopher Carey, Joshua Tobin, Deepak Perumal, Julie M. Vose, Matthew A. Lunning, Aliyah R. Sohani, Benjamin J. Chen, Shannon Buckley, Loretta J. Nastoupil, R. Eric Davis, Jason R. Westin, Nathan H. Fowler, Samir Parekh, Maher Gandhi, Sattva Neelapu, Douglas Stewart, Kapil Bhalla, Javeed Iqbal, Timothy Greiner, Scott J. Rodig, Adnan Mansoor & Michael R. Green. (2021) Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma. Haematologica 107:3, pages 690-701.
Crossref
Xiaowei Chen, Yu Wang, Xiao Qu, Fenglong Bie, Yadong Wang & Jiajun Du. (2021) TRIM58 is a prognostic biomarker remodeling the tumor microenvironment in KRAS -driven lung adenocarcinoma . Future Oncology 17:5, pages 565-579.
Crossref
Yu‐Cen Liang, Ji‐Lin Wang, Hong‐Tao Wang, Hu Liu, Hong‐Long Zhang & Yu‐Xia Liang. (2020) ADRM1 as a therapeutic target in hepatocellular carcinoma . The Kaohsiung Journal of Medical Sciences 37:1, pages 47-54.
Crossref
Cihan GÜR, Fatih KANDEMİR & Aydın GENÇ. (2020) Bortezomib ile Kalp Hasarı Oluşturulan Ratlarda Berberinin Oksidatif ve Nitrozatif Stres Üzerine Etkisi. Türk Doğa ve Fen Dergisi 9:2, pages 118-126.
Crossref
Bin Wei, Lijuan Xu, Hongxia Hui, Yuan Sun & Jingjing Wu. (2020) USP9X mRNA expression predicts clinical outcome for esophageal squamous cell carcinoma treated with cisplatin-based therapy. Clinics and Research in Hepatology and Gastroenterology 44:6, pages 932-938.
Crossref
Ali-Asghar Moghadami, Elmira Aboutalebi Vand Beilankouhi, Ashkan Kalantary-Charvadeh, Masoud Hamzavi, Bashir Mosayyebi, Hassan Sedghi, Amir Ghorbani Haghjo & Saeed Nazari Soltan Ahmad. (2020) Inhibition of USP14 induces ER stress–mediated autophagy without apoptosis in lung cancer cell line A549. Cell Stress and Chaperones 25:6, pages 909-917.
Crossref
M. Michael Dcona, Koushambi Mitra & Matthew C. T. Hartman. (2020) Photocontrolled activation of small molecule cancer therapeutics. RSC Medicinal Chemistry 11:9, pages 982-1002.
Crossref
Chao Zhang, Ying Wei, Le Xu, Kang-Cheng Wu, Liang Yang, Chao-Nan Shi, Guo-Yi Yang, Dong Chen, Fei-Fei Yu, Qi Xie, Shou-Wei Ding & Jian-Guo Wu. (2020) A Bunyavirus-Inducible Ubiquitin Ligase Targets RNA Polymerase IV for Degradation during Viral Pathogenesis in Rice. Molecular Plant 13:6, pages 836-850.
Crossref
Dakshinamurthy Sivakumar, Vikash Kumar, Michael Naumann & Matthias Stein. (2020) Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases. Journal of Biological Chemistry 295:20, pages 6972-6982.
Crossref
Olivier Coux, Barbara A. Zieba & Silke Meiners. 2020. Proteostasis and Disease. Proteostasis and Disease 55 100 .
Ahmed H. H. El-Desoky & Sachiko Tsukamoto. 2021. Marine Natural Products. Marine Natural Products 3 22 .
Suji Han, Hyemi Shin, Jeong-Woo Oh, Yun Jeong Oh, Nam-Gu Her & Do-Hyun Nam. (2019) The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling. Cancers 11:12, pages 1849.
Crossref
Maryia Karpiyevich, Sophie Adjalley, Marco Mol, David B. Ascher, Bethany Mason, Gerbrand J. van der Heden van Noort, Heike Laman, Huib Ovaa, Marcus C. S. Lee & Katerina Artavanis-Tsakonas. (2019) Nedd8 hydrolysis by UCH proteases in Plasmodium parasites. PLOS Pathogens 15:10, pages e1008086.
Crossref
Charlotte A. Mintie, Chandra K. Singh, Mary A. Ndiaye, Gregory A. Barrett-Wilt & Nihal Ahmad. (2019) Identification of Molecular Targets of Dietary Grape-Mediated Chemoprevention of Ultraviolet B Skin Carcinogenesis: A Comparative Quantitative Proteomics Analysis. Journal of Proteome Research 18:10, pages 3741-3751.
Crossref
Kun Cao, Hao Wang, Yueyang Fang, Yuan Wang, Lei Wei, Xi Chen, Zheng Jiang, Xiaochun Wei & Yong Hu. (2019) Histone Deacetylase 4 Promotes Osteosarcoma Cell Proliferation and Invasion by Regulating Expression of Proliferating Cell Nuclear Antigen. Frontiers in Oncology 9.
Crossref
Gianluca Veggiani, María Carla Rosales Gerpe, Sachdev S. Sidhu & Wei Zhang. (2019) Emerging drug development technologies targeting ubiquitination for cancer therapeutics. Pharmacology & Therapeutics 199, pages 139-154.
Crossref
Moritz Schmidt, Vanessa Altdörfer, Sarah Schnitte, Alexander Rolf Fuchs, Korbinian Nepomuk Kropp, Stefanie Maurer, Martin Rudolf Müller, Helmut Rainer Salih, Susanne Malaika Rittig, Frank Grünebach & Daniela Dörfel. (2019) The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells. Neoplasia 21:7, pages 653-664.
Crossref
Stefania Crisci, Raffaele Di Francia, Sara Mele, Pasquale Vitale, Giuseppina Ronga, Rosaria De Filippi, Massimiliano Berretta, Paola Rossi & Antonio Pinto. (2019) Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas. Frontiers in Oncology 9.
Crossref
Jerry Vriend & Robert B. Tate. (2019) Differential Expression of Genes for Ubiquitin Ligases in Medulloblastoma Subtypes. The Cerebellum 18:3, pages 469-488.
Crossref
Fengting Wang & Bo Zhao. (2019) UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10. International Journal of Molecular Sciences 20:9, pages 2250.
Crossref
Jie Wang, Shiliang Li & Honglin Li. (2019) Drug Design of “Undruggable” Targets. Chinese Journal of Chemistry 37:5, pages 501-512.
Crossref
Zhiyuan Jiang, Qingqing Zhou, Chao Ge, Jing Yang, Hong Li, Taoyang Chen, Haiyang Xie, Ying Cui, Miaomiao Shao, Jinjun Li & Hua Tian. (2019) Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma. Cancer Letters 447, pages 1-11.
Crossref
Thanh Nguyen, Minh Ho, Kyungmin Kim, Sun-Il Yun, Pushpak Mizar, James Easton, Seung Lee & Kyeong Kim. (2019) Suppression of the Ubiquitin Pathway by Small Molecule Binding to Ubiquitin Enhances Doxorubicin Sensitivity of the Cancer Cells. Molecules 24:6, pages 1073.
Crossref
Seon Min Woo & Taeg Kyu Kwon. (2019) E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway. BMB Reports 52:2, pages 119-126.
Crossref
Vibhuti Joshi, Arun Upadhyay, Ayeman Amanullah, Ribhav Mishra & Amit Mishra. 2019. Molecular Diagnostics in Cancer Patients. Molecular Diagnostics in Cancer Patients 43 72 .
Meng-Huang Wu, Ching-Yu Lee, Tsung-Jen Huang, Kuo-Yuan Huang, Chih-Hsin Tang, Shing-Hwa Liu, Kuan-Lin Kuo, Feng-Che Kuan, Wei-Chou Lin & Chung-Sheng Shi. (2018) MLN4924, a Protein Neddylation Inhibitor, Suppresses the Growth of Human Chondrosarcoma through Inhibiting Cell Proliferation and Inducing Endoplasmic Reticulum Stress-Related Apoptosis. International Journal of Molecular Sciences 20:1, pages 72.
Crossref
Zhen Dong & Hongjuan Cui. (2018) The Autophagy-Lysosomal Pathways and Their Emerging Roles in Modulating Proteostasis in Tumors. Cells 8:1, pages 4.
Crossref
Lucy Swift, Aarthi Jayanthan, Yibing Ruan, Ronald Anderson, Jessica Boklan, Tanya Trippett & Aru Narendran. (2018) Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib. Targeted Oncology 13:6, pages 779-793.
Crossref
Zainab Sabry Othman Ahmed, Xin Li, Feng Li, Hassan Ali Cheaito, Kush Patel, El‐Sayed Mohammed Mosallam, Gehad Abd El‐Fattah Hassan Elbargeesy & Q Ping Dou. (2018) Computational and biochemical studies of isothiocyanates as inhibitors of proteasomal cysteine deubiquitinases in human cancer cells. Journal of Cellular Biochemistry 119:11, pages 9006-9016.
Crossref
Neetika Lal, Vishal Nemaysh & Pratibha Mehta Luthra. (2018) Proteasome mediated degradation of CDC25C and Cyclin B1 in Demethoxycurcumin treated human glioma U87 MG cells to trigger G2/M cell cycle arrest. Toxicology and Applied Pharmacology 356, pages 76-89.
Crossref
Seyed Fazel Nabavi, Atanas G. Atanasov, Haroon Khan, Davide Barreca, Domenico Trombetta, Lara Testai, Antoni Sureda, Silvia Tejada, Rosa Anna Vacca, Valeria Pittalà, Diana Gulei, Ioana Berindan-Neagoe, Samira Shirooie & Seyed Mohammad Nabavi. (2018) Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials. Cancer Letters 434, pages 101-113.
Crossref
Yanpeng Ci, Xiaoning Li, Maorong Chen, Jiateng Zhong, Brian J. North, Hiroyuki Inuzuka, Xi He, Yu Li, Jianping Guo & Xiangpeng Dai. (2018) SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation. Protein & Cell 9:10, pages 879-889.
Crossref
Antonella Sesta, Maria Francesca Cassarino, Francesco Cavagnini & Francesca Pecori Giraldi. (2018) Role of the ubiquitin/proteasome system on ACTH turnover in rat corticotropes. Endocrine 61:3, pages 511-517.
Crossref
Ishita Gupta, Nishant K. Varshney & Sameena Khan. (2018) Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy. Frontiers in Genetics 9.
Crossref
Zi Liu, Yuqing Wu, Zijian Tao & Liang Ma. (2018) E3 ubiquitin ligase Hakai regulates cell growth and invasion, and increases the chemosensitivity to cisplatin in non‑small‑cell lung cancer cells. International Journal of Molecular Medicine.
Crossref
Luigi Alfano, Antonella Caporaso, Angela Altieri, Caterina Costa, Iris M. Forte, Carmelina A. Iannuzzi, Daniela Barone, Luca Esposito, Antonio Giordano & Francesca Pentimalli. (2017) NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer . Journal of Cellular Physiology 233:5, pages 4338-4344.
Crossref
Khondoker Alam, Alexandra Crowe, Xueying Wang, Pengyue Zhang, Kai Ding, Lang Li & Wei Yue. (2018) Regulation of Organic Anion Transporting Polypeptides (OATP) 1B1- and OATP1B3-Mediated Transport: An Updated Review in the Context of OATP-Mediated Drug-Drug Interactions. International Journal of Molecular Sciences 19:3, pages 855.
Crossref
Fahima Dilnawaz & Sanjeeb K Sahoo. (2018) Augmented Anticancer Efficacy by si-RNA Complexed Drug-Loaded Mesoporous Silica Nanoparticles in Lung Cancer Therapy. ACS Applied Nano Materials 1:2, pages 730-740.
Crossref
Lisa Maria Mustachio, Yun Lu, Masanori Kawakami, Jason Roszik, Sarah J. Freemantle, Xi Liu & Ethan Dmitrovsky. (2018) Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target. Cancer Research 78:3, pages 587-592.
Crossref
S. Sreenivasa Reddy, Karnam Shruthi, Y. Konda Prabhakar, Gummadi Sailaja & G. Bhanuprakash Reddy. (2018) Implication of altered ubiquitin-proteasome system and ER stress in the muscle atrophy of diabetic rats. Archives of Biochemistry and Biophysics 639, pages 16-25.
Crossref
Kevin Y. Guo, Lili Han, Xinyu Li, Andrew V. Yang, Jiaxiong Lu, Shan Guan, Hui Li, Yang Yu, Yanling Zhao, Jianhua Yang & Hong Zhang. (2017) Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway. Oncotarget 8:69, pages 114123-114135.
Crossref
Kristijan Ramadan & Ivan Dikic. (2017) Editorial: Ubiquitin and Ubiquitin-Relative SUMO in DNA Damage Response. Frontiers in Genetics 8.
Crossref
Shayda Hemmati, Tamanna Haque & Kira Gritsman. (2017) Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells. Frontiers in Oncology 7.
Crossref
Yi-Min Liu, Wei-Chun HuangFu, Han-Li Huang, Wei-Cheng Wu, Yi-Lin Chen, Yun Yen, Hsiang-Ling Huang, Chih-Ying Nien, Mei-Jung Lai, Shiow-Lin Pan & Jing-Ping Liou. (2017) 1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma. European Journal of Medicinal Chemistry 140, pages 84-91.
Crossref
Kamalini Ghosh, Soumasree De, Srimoyee Mukherjee, Sayantani Das, Amar Nath Ghosh & Sumita (Bandyopadhyay) Sengupta. (2017) Withaferin A induced impaired autophagy and unfolded protein response in human breast cancer cell-lines MCF-7 and MDA-MB-231. Toxicology in Vitro 44, pages 330-338.
Crossref
Chi V. Dang, E. Premkumar Reddy, Kevan M. Shokat & Laura Soucek. (2017) Drugging the 'undruggable' cancer targets. Nature Reviews Cancer 17:8, pages 502-508.
Crossref
Ahmed H. Afifi, Ippei Kagiyama, Ahmed H. El-Desoky, Hikaru Kato, Remy E. P. Mangindaan, Nicole J. de Voogd, Nagwa M. Ammar, Mohammed S. Hifnawy & Sachiko Tsukamoto. (2017) Sulawesins A–C, Furanosesterterpene Tetronic Acids That Inhibit USP7, from a Psammocinia sp. Marine Sponge . Journal of Natural Products 80:7, pages 2045-2050.
Crossref
Sukhontip Klahan, Henry Sung-Ching Wong, Shih-Hsin Tu, Wan-Hsuan Chou, Yan-Feng Zhang, Thien-Fiew Ho, Chih-Yi Liu, Shih-Ying Yih, Hsing Fang Lu, Sean Chun-Chang Chen, Chi-Cheng Huang & Wei-Chiao Chang. (2017) Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profiles. Tumor Biology 39:6, pages 101042831770557.
Crossref
Xiaojun Liu, Yanan Jiang, Jianfu Wu, Wenjuan Zhang, Yupei Liang, Lijun Jia, Jinha Yu, L.S. Jeong & Lihui Li. (2017) NEDD8-activating enzyme inhibitor, MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis through up-regulation of ATF-4. Biochemical and Biophysical Research Communications 488:1, pages 1-5.
Crossref
Tereza Nehybová, Jan Šmarda, Lukáš Daniel, Marek Stiborek, Viktor Kanický, Ivan Spasojevič, Jan Preisler, Jiří Damborský & Petr Beneš. (2017) Wedelolactone Acts as Proteasome Inhibitor in Breast Cancer Cells. International Journal of Molecular Sciences 18:4, pages 729.
Crossref
Lisa Dwane, William M. Gallagher, Tríona Ní Chonghaile & Darran P. O'Connor. (2017) The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways. Journal of Biological Chemistry 292:9, pages 3543-3551.
Crossref
Harish Potu, Luke F. Peterson, Malathi Kandarpa, Anupama Pal, Hanshi Sun, Alison Durham, Paul W. Harms, Peter C. Hollenhorst, Ugur Eskiocak, Moshe Talpaz & Nicholas J. Donato. (2017) Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma. Nature Communications 8:1.
Crossref
Kejian Wang, Vikrant Vijay & James C. Fuscoe. (2017) Stably Expressed Genes Involved in Basic Cellular Functions. PLOS ONE 12:1, pages e0170813.
Crossref
Alberto Valdés, Virginia García-Cañas, Konstantin A. Artemenko, Carolina Simó, Jonas Bergquist & Alejandro Cifuentes. (2017) Nano-liquid Chromatography-orbitrap MS-based Quantitative Proteomics Reveals Differences Between the Mechanisms of Action of Carnosic Acid and Carnosol in Colon Cancer Cells. Molecular & Cellular Proteomics 16:1, pages 8-22.
Crossref
Abir K. Panda, Sreeparna Chakraborty, Kirti Kajal, Dia Roy, Tania Sarkar & Gaurisankar Sa. 2017. Pathophysiological Aspects of Proteases. Pathophysiological Aspects of Proteases 265 296 .
Christopher N. Lewis & Jacques Galipeau. 2016. The Biology and Therapeutic Application of Mesenchymal Cells. The Biology and Therapeutic Application of Mesenchymal Cells 794 813 .
Xian-Jun Yu, Qun Zhao, Xuan-Bin Wang, Jing-Xuan Zhang & Xiao-Bo Wang. (2016) Gambogenic acid induces proteasomal degradation of CIP2A and sensitizes hepatocellular carcinoma to anticancer agents. Oncology Reports 36:6, pages 3611-3618.
Crossref
Pawel Domagala, Jolanta Hybiak, Janusz Rys, Tomasz Byrski, Cezary Cybulski & Jan Lubinski. (2016) Pathological complete response after cisplatin neoadjuvant therapy is associated with the downregulation of DNA repair genes in BRCA1 -associated triple-negative breast cancers . Oncotarget 7:42, pages 68662-68673.
Crossref
Vibhuti Joshi, Ayeman Amanullah, Arun Upadhyay, Ribhav Mishra, Amit Kumar & Amit Mishra. (2016) A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?. Frontiers in Molecular Neuroscience 9.
Crossref
Binbin Xue, Darong Yang, Jingjing Wang, Yan Xu, Xiaohong Wang, Yuwen Qin, Renyun Tian, Shengwen Chen, Qinya Xie, Nianli Liu & Haizhen Zhu. (2016) ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway. Journal of Virology 90:15, pages 6832-6845.
Crossref
Shailender Bhatia, Anna C. Pavlick, Peter Boasberg, John A. Thompson, George Mulligan, Michael D. Pickard, Hélène Faessel, Bruce J. Dezube & Omid Hamid. (2016) A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma. Investigational New Drugs 34:4, pages 439-449.
Crossref
Lopamudra Das, Shrikant Babanrao Kokate, Suvasmita Rath, Niranjan Rout, Shivaram Prasad Singh, Sheila Eileen CroweAsish K. Mukhopadhyay & Asima Bhattacharyya. (2016) ETS2 and Twist1 promote invasiveness of Helicobacter pylori -infected gastric cancer cells by inducing Siah2 . Biochemical Journal 473:11, pages 1629-1640.
Crossref
Rong Liu, Shumin Lu, Yan Deng, Shuyun Yang, Song He, Jing Cai, Fulin Qiang, Chen Chen, Weiwei Zhang, Shuyang Zhao, Li Qian, Guoxin Mao & Yingying Wang. (2015) PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis. Archives of Gynecology and Obstetrics 293:6, pages 1297-1307.
Crossref
Alexandr Paci, Peter X.H. Liu, Lingjie Zhang & Rongmin Zhao. (2016) The Proteasome Subunit Rpn8 Interacts with the Small Nucleolar RNA Protein (snoRNP) Assembly Protein Pih1 and Mediates Its Ubiquitin-independent Degradation in Saccharomyces cerevisiae. Journal of Biological Chemistry 291:22, pages 11761-11775.
Crossref
Felicity D. Herrington, Ruaidhrí J. Carmody & Carl S. Goodyear. (2016) Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity. SLAS Discovery 21:3, pages 223-242.
Crossref
Sophie Sneddon & Jenette Creaney. (2016) BAP1 mutations in mesothelioma: advances and controversies. Current Pulmonology Reports 5:1, pages 13-19.
Crossref
Maximilian Stahl, Tae Kon Kim & Amer M Zeidan. (2016) Update on acute myeloid leukemia stem cells: New discoveries and therapeutic opportunities. World Journal of Stem Cells 8:10, pages 316.
Crossref
Andreas Zanzoni & Christine Brun. (2016) Integration of quantitative proteomics data and interaction networks: Identification of dysregulated cellular functions during cancer progression. Methods 93, pages 103-109.
Crossref
Gibok Lee, Taek-In Oh, Ki Bum Um, Hyeshin Yoon, Jaekyoung Son, Byeong Mo Kim, Hong-Il Kim, Hackyoung Kim, Young Jun Kim, Chang-Soo Lee & Ji-Hong Lim. (2016) Small-molecule inhibitors of USP7 induce apoptosis through oxidative and endoplasmic reticulum stress in cancer cells. Biochemical and Biophysical Research Communications 470:1, pages 181-186.
Crossref
Lanhai Lü, Xiqiang Liu, Cheng Wang, Fengchun Hu, Jianning Wang & Hongzhang Huang. (2015) Dissociation of E-cadherin/β-catenin complex by MG132 and bortezomib enhances CDDP induced cell death in oral cancer SCC-25 cells. Toxicology in Vitro 29:8, pages 1965-1976.
Crossref
Ramzi M. Mohammad, Irfana Muqbil, Leroy Lowe, Clement Yedjou, Hsue-Yin Hsu, Liang-Tzung Lin, Markus David Siegelin, Carmela Fimognari, Nagi B. Kumar, Q. Ping Dou, Huanjie Yang, Abbas K. Samadi, Gian Luigi Russo, Carmela Spagnuolo, Swapan K. Ray, Mrinmay Chakrabarti, James D. Morre, Helen M. Coley, Kanya Honoki, Hiromasa Fujii, Alexandros G. Georgakilas, Amedeo Amedei, Elena Niccolai, Amr Amin, S. Salman Ashraf, William G. Helferich, Xujuan Yang, Chandra S. Boosani, Gunjan Guha, Dipita Bhakta, Maria Rosa Ciriolo, Katia Aquilano, Sophie Chen, Sulma I. Mohammed, W. Nicol Keith, Alan Bilsland, Dorota Halicka, Somaira Nowsheen & Asfar S. Azmi. (2015) Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology 35, pages S78-S103.
Crossref
Da-wei Wang, Zhen-ju Peng, Guang-fang Ren & Guang-xin Wang. (2015) The different roles of selective autophagic protein degradation in mammalian cells. Oncotarget 6:35, pages 37098-37116.
Crossref
Lin Ao, Derek Reichel, Di Hu, Hyunyoung Jeong, Kyung Bo Kim, Younsoo Bae & Wooin Lee. (2015) Polymer Micelle Formulations of Proteasome Inhibitor Carfilzomib for Improved Metabolic Stability and Anticancer Efficacy in Human Multiple Myeloma and Lung Cancer Cell Lines. Journal of Pharmacology and Experimental Therapeutics 355:2, pages 168-173.
Crossref
Sebastian Stintzing, Wu Zhang, Volker Heinemann, Daniel Neureiter, Ralf Kemmerling, Thomas Kirchner, Andreas Jung, Matthias Folwaczny, Dongyun Yang, Yan Ning, Ana Sebio, Stefan Stremitzer, Yu Sunakawa, Satoshi Matsusaka, Shinichi Yamauchi, Fotios Loupakis, Chiara Cremolini, Alfredo Falcone & Heinz-Josef Lenz. (2015) Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer. Molecular Cancer Therapeutics 14:10, pages 2374-2381.
Crossref
John T. Minges, Gail Grossman, Ping Zhang, Tal Kafri & Elizabeth M. Wilson. (2015) Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor. Journal of Biological Chemistry 290:41, pages 25174-25187.
Crossref
Biljana Stangeland, Awais A. Mughal, Zanina Grieg, Cecilie Jonsgar Sandberg, Mrinal Joel, Ståle Nygård, Torstein Meling, Wayne Murrell, Einar O. Vik Mo & Iver A. Langmoen. (2015) Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Oncotarget 6:28, pages 26192-26215.
Crossref
Rahul R. Deshmukh & Q. Ping Dou. (2015) Proteasome inhibitors induce AMPK activation via CaMKKβ in human breast cancer cells. Breast Cancer Research and Treatment 153:1, pages 79-88.
Crossref
Bo Han, Weilong Yao, You-Take Oh, Jing-Shan Tong, Shaohua Li, Jiusheng Deng, Ping Yue, Fadlo R. Khuri & Shi-Yong Sun. (2015) The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5. Oncotarget 6:19, pages 17532-17542.
Crossref
Liwen Wu, Jing Peng, Huimin Kong, Ping Yang, Fang He, Xiaolu Deng, Na Gan & Fei Yin. (2015) The role of ubiquitin/Nedd4-2 in the pathogenesis of mesial temporal lobe epilepsy. Physiology & Behavior 143, pages 104-112.
Crossref
Cristovao F. Lima, Marta Costa, M.F. Proença & Cristina Pereira-Wilson. (2015) Novel structurally similar chromene derivatives with opposing effects on p53 and apoptosis mechanisms in colorectal HCT116 cancer cells. European Journal of Pharmaceutical Sciences 72, pages 34-45.
Crossref
Sana Ahmed-Seghir, Caroline Pouvelle, Emmanuelle Despras, Agnès Cordonnier, Alain Sarasin & Patricia L. Kannouche. (2015) Aberrant C-terminal domain of polymerase η targets the functional enzyme to the proteosomal degradation pathway. DNA Repair 29, pages 154-165.
Crossref
Jianbiao Zhou, Ying Qing Ching & Wee-Joo Chng. (2015) Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target. Oncotarget 6:8, pages 5490-5500.
Crossref
Silke Meiners, Oliver Eickelberg & Melanie Königshoff. (2015) Hallmarks of the ageing lung. European Respiratory Journal 45:3, pages 807-827.
Crossref
B. N. P. Sah, T. Vasiljevic, S. McKechnie & O. N. Donkor. (2015) Identification of Anticancer Peptides from Bovine Milk Proteins and Their Potential Roles in Management of Cancer: A Critical Review. Comprehensive Reviews in Food Science and Food Safety 14:2, pages 123-138.
Crossref
Alessandra Rufini, Francesca Cavallo, Ivano Condò, Silvia Fortuni, Gabriella De Martino, Ottaviano Incani, Almerinda Di Venere, Monica Benini, Damiano Sergio Massaro, Gaetano Arcuri, Dario Serio, Florence Malisan & Roberto Testi. (2015) Highly specific ubiquitin-competing molecules effectively promote frataxin accumulation and partially rescue the aconitase defect in Friedreich ataxia cells. Neurobiology of Disease 75, pages 91-99.
Crossref
Peihao Zheng, Honggang Guo, Guangchao Li, Siqi Han, Fei Luo & Yi Liu. (2015) PSMB4 promotes multiple myeloma cell growth by activating NF-κB-miR-21 signaling. Biochemical and Biophysical Research Communications 458:2, pages 328-333.
Crossref
Deborah J Marsh. (2015) Networks regulating ubiquitin and ubiquitin-like proteins promise new therapeutic targets. Endocrine-Related Cancer 22:1, pages E1-E3.
Crossref
Daniel E Johnson. (2015) The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors. Endocrine-Related Cancer 22:1, pages T1-T17.
Crossref
MEI JI, HUIRONG SHI, YA XIE, ZHAO ZHAO, SHUNSHUANG LI, CHENG CHANG, XINGHAN CHENG & YUE LI. (2015) Ubiquitin specific protease 22 promotes cell proliferation and tumor growth of epithelial ovarian cancer through synergy with transforming growth factor β1. Oncology Reports 33:1, pages 133-140.
Crossref
Lexun Lin, Ying Qin, Heng Wu, Yang Chen, Shuo Wu, Xiaoning Si, Hui Wang, Tianying Wang, Xiaoyan Zhong, Xia Zhai, Lei Tong, Bo Pan, Fengmin Zhang, Zhaohua Zhong, Yan Wang & Wenran Zhao. (2015) Pyrrolidine dithiocarbamate inhibits enterovirus 71 replication by down-regulating ubiquitin–proteasome system. Virus Research 195, pages 207-216.
Crossref
Jia Liu, Shavali Shaik, Xiangpeng Dai, Qiong Wu, Xiuxia Zhou, Zhiwei Wang & Wenyi Wei. (2015) Targeting the ubiquitin pathway for cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:1, pages 50-60.
Crossref
Lydia Mata-Cantero, Sofía Lobato-Gil, Fabienne Aillet, Valérie Lang & Manuel S. Rodriguez. 2015. Stress Response Pathways in Cancer. Stress Response Pathways in Cancer 225 264 .
Robert A. Chong, Kenneth Wu, Jordan Kovacev & Zhen-Qiang Pan. 2015. NF-kappa B. NF-kappa B 339 354 .
Naoya Saito, Keiichi Sakakibara, Takuji Sato, Jonathan M. Friedman, Donald W. Kufe, Daniel D. VonHoff & Takumi Kawabe. (2014) CBS9106-Induced CRM1 Degradation Is Mediated by Cullin Ring Ligase Activity and the Neddylation Pathway. Molecular Cancer Therapeutics 13:12, pages 3013-3023.
Crossref
Brian D. Cholewa, Molly C. Pellitteri-Hahn, Cameron O. Scarlett & Nihal Ahmad. (2014) Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAF V600E Mutant Melanoma Cells . Journal of Proteome Research 13:11, pages 5041-5050.
Crossref
Jerry Vriend & Russel J. Reiter. (2014) Melatonin as a proteasome inhibitor. Is there any clinical evidence?. Life Sciences 115:1-2, pages 8-14.
Crossref
Annette Hille-Rehfeld. (2014) Halogenierte Naturstoffe. Chemie in unserer Zeit 48:5, pages 402-405.
Crossref
Andreas A. Argyriou, Guido Cavaletti, Jordi Bruna, Athanasios P. Kyritsis & Haralabos P. Kalofonos. (2014) Bortezomib-induced peripheral neurotoxicity: an update. Archives of Toxicology 88:9, pages 1669-1679.
Crossref
Marta Celegato, Dolores Fregona, Maurizio Mongiat, Luca Ronconi, Cinzia Borghese, Vincenzo Canzonieri, Naike Casagrande, Chiara Nardon, Alfonso Colombatti & Donatella Aldinucci. (2014) Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts. Future Medicinal Chemistry 6:11, pages 1249-1263.
Crossref
Sebastian Stintzing & Heinz-Josef Lenz. (2014) Molecular Pathways: Turning Proteasomal Protein Degradation into a Unique Treatment Approach. Clinical Cancer Research 20:12, pages 3064-3070.
Crossref
Ana Cristina Andérica-Romero, Laura Escobar, Teresa Padilla-Flores & José Pedraza-Chaverri. (2014) Insights in cullin 3/WNK4 and its relationship to blood pressure regulation and electrolyte homeostasis. Cellular Signalling 26:6, pages 1166-1172.
Crossref
Jiankang Zhang, Jiayi Cao, Lei Xu, Yubo Zhou, Tao Liu, Jia Li & Yongzhou Hu. (2014) Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors. Bioorganic & Medicinal Chemistry 22:11, pages 2955-2965.
Crossref
Larissa da Costa Souza, Ricardo Camargo, Marilene Demasi, Jaime Martins Santana, Cézar Martins de Sá & Sonia Maria de Freitas. (2014) Effects of an Anticarcinogenic Bowman-Birk Protease Inhibitor on Purified 20S Proteasome and MCF-7 Breast Cancer Cells. PLoS ONE 9:1, pages e86600.
Crossref
Bumki Min & Gwan-Su Yi. (2014) Inference of Disease E3s from Integrated Functional Relation Network. Inference of Disease E3s from Integrated Functional Relation Network.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.